Trial intelligence / Profile preview

Suture-Free Ophthalmic Hydrogel for Ocular Surface Tissue Adhesion

NCT07608367Recruiting

Start
Oct 2025
Primary completion
Jan 2027
Countries
1
01

Overview

Open-label, single-arm trial in ocular surface disease (OSD). Primary endpoint: Safety Evaluation Items at 1 month. Started Oct 2025; status: recruiting.

02

Conditions

ocular surface disease (OSD)

Beyond the preview

Go deeper on NCT07608367.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07608367.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call